We described previously the cDNA cloning of three functional rat histamine H 3 receptor (rH 3 R) isoforms as well as the differential brain expression patterns of their corresponding mRNAs and signaling properties of the resulting rH 3A , rH 3B , and rH 3C receptor isoforms (Mol Pharmacol 59:1-8). In the current report, we describe the cDNA cloning, mRNA localization in the rat central nervous system, and pharmacological characterization of three additional rH 3 R splice variants (rH 3D , rH 3E , and rH 3F ) that differ from the previously published isoforms in that they result from an additional alternative-splicing event. These new H 3 R isoforms lack the seventh transmembrane (TM) helix and contain an alternative, putatively extracellular, C terminus (6TM-rH 3 isoforms). After heterologous expression in COS-7 cells, radioligand binding or functional responses upon the application of various H 3 R ligands could not be detected for the 6TM-rH 3 isoforms. In contrast to the rH 3A receptor (rH 3A R), detection of the rH 3D isoform using hemagglutinin antibodies revealed that the rH 3D isoform remains mainly intracellular. The expression of the rH 3D-F splice variants, however, modulates the cell surface expression-levels and subsequent functional responses of the 7TM H 3 R isoforms. Coexpression of the rH 3A R and the rH 3D isoforms resulted in the intracellular retention of the rH 3A R and reduced rH 3A R functionality. Finally, we show that in rat brain, the H 3 R mRNA expression levels are modulated upon treatment with the convulsant pentylenetetrazole, suggesting that the rH 3 R isoforms described herein thus represent a novel physiological mechanism for controlling the activity of the histaminergic system.
application of various H 3 R ligands could not be detected for the 6TM-rH 3 isoforms. In contrast to the rH 3A receptor (rH 3A R), detection of the rH 3D isoform using hemagglutinin antibodies revealed that the rH 3D isoform remains mainly intracellular. The expression of the rH 3D-F splice variants, however, modulates the cell surface expression-levels and subsequent functional responses of the 7TM H 3 R isoforms. Coexpression of the rH 3A R and the rH 3D isoforms resulted in the intracellular retention of the rH 3A R and reduced rH 3A R functionality. Finally, we show that in rat brain, the H 3 R mRNA expression levels are modulated upon treatment with the convulsant pentylenetetrazole, suggesting that the rH 3 R isoforms described herein thus represent a novel physiological mechanism for controlling the activity of the histaminergic system.
Histamine receptors are members of the superfamily of seven transmembrane domain (7TM) G-protein-coupled receptors (GPCRs). The histamine H 3 receptor (H 3 R) was pharmacologically identified in 1983 and holds great promise as a target for the development of therapeutics for numerous disorders, including obesity, epilepsy, and such cognitive diseases as attention deficit hyperactivity disorder and Alzheimer's disease (see Bakker, 2004; Leurs et al., 2005 for reviews). The cloning of the H 3 R cDNA allowed for the subsequent cloning of related sequences, including a variety of H 3 R isoforms from different species (for review, see Bakker, 2004; Leurs et al., 2005) .
Alternative splicing of pre-mRNA represents a widespread mechanism for increasing the variability of eukaryotic gene expression by generating structurally distinct isoforms from a single gene. Alterations in the expression of GPCR isoforms could be associated with disease (Schmauss et al., 1993) . Although ␣ 1 -AR adrenoceptors and dopamine receptors are prime examples of alternatively spliced GPCRs (Cogé et al., 1999; Kilpatrick et al., 1999; Hawrylyshyn et al., 2004) , more and more GPCR splice variants are identified for other members of the GPCR superfamily. A variety of H 3 R isoforms from several species has been reported (for review, see Bakker, 2004; Leurs et al., 2005) . In addition to the 445 amino acids containing rH 3A R, two presumably nonfunctional truncated isoforms (reported as rH 3T or rH 3(nf1) and rH 3(nf2) ) (Drutel et al., 2001; Morisset et al., 2001 ) and three functional rH 3 R isoforms have been detected: rH 3B , rH 3C , and the rH 3(410) receptor, generated by deletions in the third intracellular loop of the rH 3 R of 32, 48, and 35 amino acids, respectively. Because several H 3 R isoforms have been shown to possess specific pharmacological characteristics in terms of ligand-binding and initiation of signal-transductions events (Drutel et al., 2001) , the H 3 R mRNA splicing can significantly affect cellular responses to histamine. A detailed understanding of the spectrum of H 3 R splice variants in different species is of importance not only for the understanding of histaminergic system, but also for future drug development efforts.
In the present study, we describe the identification of three additional 6TM-rH 3 isoforms after an RT-PCR approach using rat brain cDNA. Although the mRNA for these 6TM-rH 3 isoforms is detected in the rat brain, in attempting their characterization, we failed to detect radioligand binding using H 3 R specific radioligands as well as functional effects upon heterologous expression in COS-7 cells. Coexpression of 7TM-rH 3 Rs with the 6TM-rH 3 isoforms, however, revealed that the 6TM-rH 3 isoforms inhibit the cell surface trafficking and subsequent functional activity of the 7TM-rH 3 Rs. The regulation of the expression of the 6TM-rH 3 isoforms may therefore represent a novel mechanism for the regulation of H 3 R functionality. To study possible in vivo functional relationships between 7TM-rH 3 R and 6TM-rH 3 isoforms, relative expression levels were analyzed in a model of generalized tonic-clonic seizures induced by pentylenetetrazole (PTZ). Data from a study on kainic acid-induced status epilepticus indicates that systemic kainic acid induces a direct or indirect selective increase in H 3 R isoforms with a full third intracellular loop in areas that suffer rapid neuronal damage (Lintunen et al., 2005) . No data are currently available regarding whether 7TM-rH 3 R and 6TM-rH 3 isoforms are similarly regulated under pathophysiological conditions in the rat brain. The PTZ seizure model used in this study allows us to determine whether an H 3 R isoform-specific response occurs in a pathological setting. Our findings therefore uncover a new mechanism that may control the regulation of H 3 R activity in the brain.
Materials and Methods
Materials. Immepip, clobenpropit, and thioperamide were synthesized at the department of Medicinal Chemistry at the Vrije Univeristeit Amsterdam. Gifts of pcDEF 3 (Dr. J. Langer, Robert Wood Johnson Medical School, Piscataway, NJ), pTLN21CRE-Luc (Dr. W. Born, National Jewish Medical and Research Center, Denver, CO), and of the cDNAs encoding the PTX-insensitive mutant rat G␣ i/o proteins G␣ i1 C 351 I, G␣ i2 C 352 I, G␣ i3 C 351 I, and G␣ o C 351 I (Dr. G. Milligan, University of Glasgow, Glasgow, UK), the cDNA encoding the FLAG-tagged rH 3A R (Dr. F. Cogé, Institut de Recherches Servier, Croissy sur Seine, France), the cDNA encoding the human histamine H 1 receptor (Dr. H. Fukui, University of Tokushima, Tokushima, Japan), the cDNA encoding the KSHV-GPCR ORF74 (Dr.
T. Schwartz, University of Copenhagen, Copenhagen, Denmark), mianserin hydrochloride (Organon NV, The Netherlands), and the HA antibody and rhodamine-labeled secondary antibody (Dr. J. van Minnen, Vrije Universiteit, Amsterdam, The Netherlands), are greatly acknowledged. All other materials were from commercial suppliers.
Constructs. The reverse transcription and PCR amplification for cloning of the rH 3D-F (6TM-rH 3 ) isoform cDNAs were performed as described previously (Drutel et al., 2001) . The full-length cDNAs were isolated with primers overlapping the rat H 3 R cDNA sequence. The forward sequence included a Kozak sequence (underlined) (5Ј-CCG CCA CCA TGG AGC GCG CGC CGC CCG ACG GGC TG-3Ј). The reverse sequence was based on cDNA for rat orphan GPCR (Genbank accession number AB015646) (5Ј-CTC TAC CCC ATA ACC ACC CAC C-3Ј). The use of these primers resulted in the amplification of at least three different products. After cloning in pCRII-TOPO, the cDNAs were sequenced on both DNA strands and subcloned in pcDNA 3 . The sequence of the identified rH 3F isoform is identical to one of the sequences found in the GenBank database (accession number AB015646; GI: 6681587), the sequences of the rH 3D and rH 3E isoforms have been deposited in the GenBank database (accession numbers DQ112342 and DQ112343, respectively). The hydropathic profile of the H 3D-F isoforms was analyzed using the TMHMM Server at the Center for Biological Sequence Analysis, Technical University of Denmark, DTU, Lyngby, Denmark (http:// www.cbs.dtu.dk/services/TMHMM/).
Construction of rH 3 R-G␣ Protein Fusion Constructs. Fusion proteins between the rat H 3 R and PTX-insensitive mutant rat G␣-proteins of the G i/o class were created by PCR using Turbo Pfu to remove the translation initiation codon from the G␣-protein cDNA sequence and the stop codon from the rH 3A R cDNA sequence.
HA-Tagging of the rH 3 R Isoforms. N-Terminal hemagglutinin (HA)-tagged expression constructs of the rH 3A R and rH 3D isoform were generated by PCR (5Ј-GCC ACC ATG GGC TAC CCA TAC GAC GTC CCA GAC TAC GCC GCG GAG CGC GCG CCG C-3Ј) and cloned into pcDNA 3.1 (Invitrogen, Leek, The Netherlands). Construct integrity was verified by sequence analysis.
Animals. The study was conducted in accordance with the European Convention (1986) guidelines and approved by the local committee for Animal Experiments and the Provincial State Office of Western Finland and the Animal Ethics Committee of Abo Akademi University. Male Sprague-Dawley rats (260-280 g) were given PTZ (50 mg/kg, i.p.). Animals were stunned with CO 2 and killed by decapitation 6 h (PTZ, n ϭ 3), 24 h (PTZ, n ϭ 3), and 48 h (PTZ, n ϭ 3; saline control, n ϭ 3) after injection.
In Situ Hybridization Histochemistry. Probes were labeled with deoxy- [␣- 33 P]ATP (PerkinElmer Life and Analytical Sciences, Boston, MA) at their 3Ј ends using terminal deoxynucleotide transferase (Promega, Madison, WI), and subsequent in situ hybridization histochemistry was performed essentially as described previously (Drutel et al., 2001 ). The following oligo-probe sequence was used for detecting H 3DEF isoform mRNAs: 5Ј-AAG TTT CCC GAG GCG CTC GAC ACA GTA ATC GGG GAT GCA GCG GCC-3Ј.
Image Analysis and Data Interpretation. Autoradiographic films were quantified by digitizing the film images using the MCID 5ϩ image analysis system (Imaging Research, St. Catherines, ON, Canada) and by measuring gray scale pixel values. The relative optic density was converted to integrated optic density based on a curve derived from 14 C standards exposed to films. Gray scale values were determined by using a total of four sections for each animal.
Cell Culture and Transfection. African green monkey kidney COS-7 cells were maintained and transfected as described previously (Drutel et al., 2001; Bakker et al., 2004a) . HEK 293 cells were cultures under similar conditions and transfected with cDNA encoding the rH 3A R using the LipofectaminePlus method according to the manufacturer's protocols.
Reporter-Gene Assay. H 3 R isoform-mediated modulation of cAMP mediated gene transcription activity was measured using the luciferase reporter-gene plasmid pTLNC121-3 (2.5 g/10 6 cells) containing 21 cAMP-responsive elements. Luminescence was assayed 48 h after incubation of transfected cells with ligands as described previously (Bakker et al., 2004b 125 I using the Iodogen method (Pierce, Rockford, IL) and subsequently used in ORF74 radioligand binding studies as described previously (Smit et al., 2002) .
Detection of Tagged rH 3 Rs. In the enzyme-linked immunosorbent assays (ELISA), a mouse anti-HA monoclonal primary antibody was used as primary antibody, and a goat anti-mousehorseradish peroxidase conjugate as secondary antibody for the detection of tagged rH 3 Rs in transfected cells. The 3,3Ј-, 5,5Ј-tetramethylbenzidine liquid substrate system for ELISA was used as substrate and the optical density was measured at 450 nm using a Victor 2 Wallac multilabel counter (PerkinElmer Life and Analytical Sciences). The same primary antibody was used for immunocytochemistry in conjunction with a secondary rhodamine labeled goat-anti-mouse antibody. Permeabilization of cells was achieved by an optional incubation of the cells for 5 min with 0.5% Nonidet P-40 in TBS before antibody application. For imaging, coverslips were mounted in 90% glycerol containing 0.02 M TrisHCl, pH 8.0, 0.002% NaN 3 , and 2% 1,4-diazabicyclo-(2,2,2)-octane (Merck, Darmstadt, Germany).
Time-Resolved FRET. The time-resolved fluorescence resonance energy transfer (FRET) experiments were conducted essentially as described previously (Bakker et al., 2004a) . Energy transfer was measured by exciting the Eu 3ϩ at 320 nm and monitoring the allophycocyanin emission for 1 ms at 665 nm using a Novostar (BMG LABTECH GmbH, Offenburg, Germany) configured for time-resolved fluorescence after a 50-s delay.
Cross-Linking and Immunoblotting of rH 3A Receptors. Cells were harvested by centrifugation, and the resulting pellet was resuspended in 150 l of cross-linking buffer (150 mM NaCl, 100 mM Na-HEPES, 5 mM EDTA, pH 7.5, and 5 mM DTT) to give a final protein concentration of approximately 0.5 mg/ml. The samples were incubated at room temperature with continual mixing for 12 min with either a 0.12 mM or a 0.25 mM concentration of the cell permeable cross-linker bis(sulfosuccinimidyl)suberate (BS3), after which the cross-linking mixture was removed by centrifugation and the resultant pellet was used for immunoblotting as described previously (Chazot et al., 2001) . Immunoblots were probed either with anti-H 3C 188-197Cys antibody (Shenton et al., 2005 ) at a 0.2 g/ml, or with an anti-H 3 329-358 antibody used at a final protein concentration of 1.5 g/ml (Chazot et al., 2001) . Analytical Methods. All data shown are expressed as mean Ϯ S.E.M. Data from radioligand binding assays and functional assays data were evaluated by a nonlinear, least-squares curve-fitting procedure using Prism (GraphPad Software, Inc., San Diego, CA).
Results

Cloning of cDNAs Encoding Additional Rat H 3 R Isoforms
The existence of additional H 3 R isoforms was investigated by RT-PCR analysis of rat whole-brain total RNA using specific primers 1 and 2 (see Materials and Methods), and revealed the existence of three previously uncharacterized fulllength cDNAs with putative corresponding proteins of 497 (rH 3D ), 465 (rH 3E ), and 449 (rH 3F ) amino acids. The amino acid sequence of the rH 3F isoform corresponds to one of the sequences found in the GenBank database (accession number AB015646; GI: 6681587). These three new rH 3 isoforms correspond in a large part to the sequences of rat histamine H 3 R isoforms A, B, and C (rH 3A R, rH 3B R, and rH 3C R, respectively) and exhibit exactly the same differences in length for the third intracellular loop (Fig. 1A) . This insertion in the third intracellular loop in the rH 3D , rH 3E , and rH 3F isoforms seems to be created by a retention/deletion system already described for the third intracellular loop (Cogé et al., 2001; Drutel et al., 2001; Morisset et al., 2001 ). However, the rH 3D , rH 3E , and rH 3F isoforms differ from the rH 3A R, rH 3B R, and rH 3C R in their C-terminal region, in which the last C-terminal 53 amino acids, which correspond to the seventh transmembrane-domain and carboxyl terminus of the rH 3A R, rH 3B R, and rH 3C R proteins, are replaced by a sequence of 105 amino acids that do not share any homology with the last 53 C-terminal amino acids of the rH 3A R, rH 3B R, and rH 3C R. Sequence analysis of the rH 3 R gene indicates that the alternative C-terminal domain that is found in the rH 3D-F isoforms is due to a change in the open reading frame upon alternative splicing using previously unidentified exon/intron junctions present within the rH 3 R gene (see Fig. 1B ). Analysis of the hydropathic profile of the rH 3D , rH 3E , and rH 3F isoforms does not reveal a clear putative seven transmembrane domain (Fig. 2, A and B) . Therefore, the rH 3D , rH 3E , and rH 3F isoforms are predicted to possess only six transmembrane domains 6TM-rH 3 isoforms) and an extracellular C-teriminal domain (Fig. 2, C and D) .
Heterologous Expression of Epitope-Tagged rH 3 R Isoforms. We have successfully characterized the rH 3A R, rH 3B R, and rH 3C R using COS-7 cells heterologously expressing these receptors (Drutel et al., 2001) . We therefore used the same approach in this study to characterize the three additional 6TM-rH 3 isoforms described herein. To evaluate the cell surface expression of the 6TM-rH 3 isoforms, we generated the cDNAs coding for the N-terminally HA-tagged rH 3A R (HA-rH 3A R) and the N-terminally HA-tagged rH 3D (HA-rH 3D ) isoform by PCR. Although we detected clear immunological evidence for the cell surface expression of the HA-rH 3A R with the use of an ELISA assay using anti HA-antibodies on intact cells, we can hardly detect the HA-rH 3D isoforms on the cell surface on intact cells (Fig. 2E ). We observe, however, a clear immunofluorescent signal upon permeabilization of cells expressing the HA-rH 3D isoform ( Fig. 2E ), indicating successful synthesis of the HA-tagged rH 3D isoform protein and retention of the HA-tagged rH 3D isoform inside the cell. There is an apparent difference in detection of the HA-rH 3D isoform versus the HA-rH 3A R, which might indicate differences in, for example, the rate of synthesis, the inherent stability, or the rate of degradation of the H 3 isoforms, but we have not pursued this issue further. To evaluate the plasma membrane localization of the HA-rH 3A R and the HA-rH 3D isoform, we subsequently performed immunocy- The rH 3B R and rH 3C R isoforms exhibit amino acid deletions in the third intracellular loop of the rH 3 R protein compared with the full-length rH 3A R. The rH 3D , rH 3E , and rH 3F isoforms differ from the rH 3A R, rH 3B R, and rH 3C R isoforms, respectively, in an alternative C-terminal domain as a result of an additional splicing event. Indicated above the amino acids are the seven transmembrane domains as they are found for the rH 3A R, rH 3B R, and rH 3C R isoforms (TM1 through TM7). B, diagram of the exon/intron structure of the rat H 3 R gene on chromosome 3 (Genbank accession number NM_053506.1; GI:16758263) and the resulting amino acid (aa) sequences found in rH 3A-C receptors and rH 3D-E isoforms generated by retention/ deletion of the pseudointrons. The exon/intron junctions within the rH 3 R gene are indicated in bold (GT and AG), whereas the codon that corresponds to the cysteine (C) found in the rH 3D-F isoforms (formed by TG and T) is underlined. For simplicity, only part of the exon/intron structure of the rat H 3R gene and of the rH 3 R gene sequence is shown (indicated by //). See Morisset et al. (2001) for an overview of the exon/intron structure of the rH 3 R gene corresponding to the two presumably nonfunctional H 3 R isoforms, H 3(nf1) and H 3(nf2) , and the four previously described functional shorter isoforms, rH 3B (rH 3(413) ), rH 3(410) , and rH 3C (rH 3(397) ).
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at ASPET Journals on April 1, 2017 molpharm.aspetjournals.org tochemistry studies using rhodamine labeled anti-HA antibodies. Plasma membrane localization of the rhodamine-derived fluorescence was easily detected using cells expressing HArH 3A Rs in intact cells (Fig. 2F , top left) and only a limited intracellular fluorescence was observed in Nonidet P40-permeabilized cells (Fig. 2F , top right). In contrast, corroborating the findings obtained by the ELISA studies, using cells transfected with cDNA encoding the HA-rH 3D isoform, appreciable rhodamine-derived fluorescence is detected only in permeabilized cells (Fig. 2F, bottom right) and not on intact cells (Fig. 2F,  bottom left) . Moreover, no plasma membrane localization of the rhodamine-derived fluorescence was detected using permeabilized HA-rH 3D isoform-expressing cells. These data indicate an intracellular localization for the HA-rH 3D isoform. (Fig. 3A) . Likewise, we did not detect [N ␣ -methyl-3 H]histamine binding to membranes of cells transfected with cDNAs encoding the 6TM-rH 3 isoforms (data not shown). Fig. 2 . Topology of the rH 3 R isoforms. Prediction of the topology of the rH 3A R (A) versus the rH 3D R (B), as predicted by the TMHMM Server at the Center for Biological Sequence Analysis, Technical University of Denmark, DTU (http://www.cbs.dtu.dk/services/TMHMM/). Indicated by the solid line are the probabilities for localization on the extracellular side (outside); the probabilities of localization on the intracellular side (inside) are indicated by the dotted lines. The probability for transmembrane (TM) domains are indicated by the filled areas. From these two plots, it can be deduced that seven TM domains are predicted for the rH 3A R, whereas for the rH 3D R, only six TM domains are predicted, as indicated above the graphs. C, graphical representation of the topology of the rH 3A , rH 3B , and rH 3C receptors, versus the rH 3D , rH 3E , and rH 3F isoforms (D). In contrast to the rH 3A , rH 3B , and rH 3C receptors, the rH 3D , rH 3E , and rH 3F isoforms are predicted to possess an extracellular C-terminal domain. Also indicated in C and D are the variations in the third intracellular loop between the isoforms. E and F, immunological detection of N-terminally HA-tagged rH 3A Rs (HA-rH 3A ) and the N-terminally HAtagged rH 3D isoform (HA-rH 3D ) on transfected COS-7 cells. E, Detection of HA-rH 3A Rs and the HA-rH 3D isoform in intact cells versus cells that have been permeabilized using 0.5% Nonidet P-40 in an ELISA assay. F, immunocytochemical detection of HA-tagged rH 3 R isoforms using a rhodamine conjugated antibody directed against the HA-tag. Detection of HA-rH 3A Rs on intact COS-7 cells (top left) and in permeabilized cells (top right). Detection of the HA-rH 3D isoform on intact cells (bottom left) and in permeabilized cells (bottom right). IPP binding was detected to membrane fractions of cells transfected with an equal amount of cDNA coding for either the rH 3D , rH 3E , or rH 3F isoform. B, dose-dependent modulation of 10 mM forskolin induced responses by histamine, immepip, and R(␣)-methylhistamine using COS-7 cells cotransfected with 5 mg/10 6 cells of both pcDEF 3 rH 3A R and a CREB-responsive firefly-luciferase reporter gene (pTLNC121CRE). C, modulation of forskolin (10 mM) induced responses by 10 mM histamine, R(␣)-methylhistamine (RaMH), and thioperamide using cells transfected with both pcDEF 3 rH 3A R and pTLNC121CRE. The forskolin-induced responses are set to 100% as indicated by "control". D, effects of 10 mM R(␣)-methylhistamine on forskolin (10 mM) induced responses using cells cotransfected with either pcDEF 3 rH 3A R, pcDEF 3 rH 3D , pcDEF 3 rH 3E , or pcDEF 3 rH 3F , and pTLN121CRE. The forskolin induced responses are set to 100% as indicated by the dashed line.
Functional Assays. The H 3 R couples to members of the G i/o family of G-proteins to inhibit adenylyl cyclase activity and subsequently inhibits the formation of intracellular cAMP (Leurs et al., 2005) . Cotransfection of COS-7 cells with the rH 3A R encoding cDNA together with pTLN121CRE, a cAMP-responsive element-binding protein (CREB)-responsive firefly-luciferase reporter gene, allowed us to monitor H 3 R-induced modulation of forskolin-induced reporter-gene expression. In concert with the G i/o -coupled nature of the H 3 R (see Leurs et al., 2005) , treatment of cotransfected cells with varying concentrations of the H 3 R agonists immepip, R(␣)-methylhistamine, and histamine results in the dosedependent inhibition of 10 mM forskolin-induced firefly-luciferase expression by approximately 60% with EC 50 values of approximately 2, 7, and 43 nM, respectively (Fig. 3B) , in rH 3A R-expressing cells. Under these assay conditions, we do not observe constitutive activity for the rH 3A R because the inverse H 3 R agonist thioperamide (Leurs et al., 2005) is without effect on the forskolin-induced luciferase expression (Fig. 3C) . Although 1 mM R(␣)-methylhistamine potently induces signaling via the rH 3A R, under the same assay conditions, R(␣)-methylhistamine is without effect on the forskolin-induced firefly-luciferase expression in cells cotransfected with cDNAs encoding the reporter gene and either of the 6TM-rH 3 isoforms (Fig. 3D ).
Is There a Role for the 6TM-rH 3 Isoforms?
Detection of Epitope-Tagged rH 3 R Isoforms in Coexpression Studies. The immunological and immunocytochemistry data obtained with the N-terminally HA-tagged HA-rH 3D isoform indicates poor plasma membrane expression of the rH 3D isoform (Fig. 2, E and F) . In addition, in cells transfected with cDNA encoding either of the 6TM-rH 3 isoforms we have been unable to detect 1) specific 125 IPP or [N ␣ -methyl-3 H]histamine binding (Fig. 3A) and 2) modulation of forskolin-induced transcriptional events that are otherwise modulated by rH 3A R activation under the same conditions. In recent years, accumulating evidence suggests that some GPCRs [e.g., the GABA B receptors (White et al., 1998) and odorant receptors (Hague et al., 2004a) ] require particular protein-protein interactions to allow proper plasma membrane expression. It seems that the 6TM-rH 3 isoforms are retained intracellularly; we postulated, therefore, that the additional expression of GPCRs might aid the cell surface expression of the 6TM-rH 3 isoforms. Conversely, the 6TM-rH 3 isoforms may possibly retain the coexpressed GPCRs intracellularly by acting as dominant-negative isoforms.
Do the 6TM-rH 3 Isoforms Interfere with Cell Surface Expression of 7TM-rH 3 Rs? We cotransfected COS-7 cells with the cDNAs coding for the HA-rH 3A R and the rH 3D isoform. Similar to the effects of coexpression of alternative splice variants of human ␣ 1A -adrenoceptors (Cogé et al., 1999) , we found that the coexpression of the rH 3D isoform reduced the expression of the HA-rH 3A R at the plasma membrane. This phenomenon is observed using either an ELISA assay on intact cells or by applying immunocytochemistry techniques using a rhodamine labeled anti-HA antibody (Fig.  4, A and B, respectively) .
Evaluation of Ligand-Binding Sites upon Coexpression of 7TM-H 3 R and 6TM-rH 3 Isoforms. To evaluate whether the loss of HA-rH 3A R-derived immunofluorescence at the cell surface upon coexpression of the rH 3D isoform also results in a loss of ligand binding sites for H 3 R ligands we performed radioligand binding assays. As shown in Fig. 3A , 125 IPP binding sites are detected upon the expression of 7TM-rH 3 Rs (Drutel et al., 2001) , such as the rH 3A R, whereas expression of the 6TM-rH 3 isoforms does not result in the formation of 125 IPP binding sites. The transfection of 0.25 mg/10 6 cells of cDNA coding for the rH 3A R resulted in the expression of 2.5 pmol/mg of protein 125 IPP binding sites. Coexpression of the rH 3A R together with the rH 3D isoform, however, resulted in an rH 3D -isoform gene-dosage-dependent reduction of rH 3A R-derived 125 IPP binding sites (Fig. 5A) ; the remaining 125 IPP binding sites exhibit a pharmacological indistinguishable from that of the rH 3A R (pK b for 125 IPP, 8.1 Ϯ 0.1; pK i values for immepip and thioperamide, 6.9 Ϯ 0.2 and 7.6 Ϯ 0.1, respectively). The coexpression of the rH 3E or rH 3F isoform together with the rH 3A R resulted in a similar reduction of 125 IPP binding sites (Fig. 5, B and C, respectively) , indicating that the 6TM-rH 3 isoforms interfere with the expression of the rH 3A R. The maximal inhibition of 125 IPP binding sites (as evaluated by a transfection of cells with an rH 3A R/6TM-rH 3 isoform cDNA ratio of 1:10) is ϳ50 to 75% (Fig. 5, A-C) . To evaluate whether the observed inhibition of 125 IPP binding-site expression is specific for the 6TM-rH 3 isoforms, we performed additional experiments in which we cotransfected cells with the same amount of rH 3A R cDNA in combination with various amounts of cDNA encoding the human histamine H 1 receptor (hH 1 R) (Fig. 5D) . Although the transfection of COS-7 cells with the hH 1 R cDNA resulted in the formation of binding-sites for the H 1 R radioligand [
3 H]mepyramine with pharmacological characteristics of the hH 1 R (data not shown), no specific 125 IPP binding was detected in hH 1 Rexpressing cells (Fig. 5D) . Cotransfection of cells with cDNAs encoding both the rH 3A R and the hH 1 R, however, did not influence the formation of 125 IPP binding sites. Similar to the findings with the hH 1 R, expression of the rat H 2 R (rH 2 R) or the viral chemokine receptor from Karposi's sarcoma herpes virus KSHV-GPCR (also known as ORF74) in COS-7 cells resulted in the formation of binding sites for the H 2 R radioligand 125 IAPT and 125 I-CXCL8, a radioligand for ORF74, respectively, but not in the formation of 125 IPP binding sites. Coexpression of the rH 3A R with either the rH 2 R or ORF74, however, did not affect the formation of rH 3A R-derived 125 IPP binding sites (Fig. 5E ). We also evaluated the effects of the coexpression of the rH 3B R and rH 3C R with the rH E and rH F isoforms, respectively, on the formation of 125 IPP binding sites. Similar to the expression of the rH 3A R, expression of the rH 3B R or rH 3C R in COS-7 cells results in the formation of 125 IPP binding sites (Drutel et al., 2001 ). Coexpression of the rH 3B R or rH 3C R together with either the rH 3E or rH 3F isoform resulted in an I-CXCL8 binding assays, respectively (data not shown). In each condition, the total amount of cDNA has been kept constant using pcDEF 3 . rH 3E isoform and rH 3F isoform gene-dosage dependent reduction of rH 3B R-derived (Fig. 5F ) and rH 3C R-derived (Fig.  5G) 125 IPP binding sites, respectively. The maximal inhibition of 125 IPP binding sites, as evaluated by a transfection of cells with an rH 3B R or rH 3C R-to-6TM-rH 3 isoform cDNA ratio of 1:10 is ϳ50 to 75% (Fig. 5, F and G) , similar to our findings on the coexpression of the rH 3A R with the 6TM-rH 3 isoforms (Fig. 5, A-C) .
Although the coexpression of the rH 3A R with the rH 3D isoform inhibits the formation of 125 IPP binding sites, the remaining 125 IPP binding sites exhibit unchanged pharmacological characteristics of the rH 3A R, as evidenced by its unchanged affinity for IPP (Fig. 5H) . Taken together, these radioligand-binding data clearly demonstrate that the expression of the 6TM-rH 3 isoforms selectively interferes with the expression of the 7TM-rH 3 Rs.
Evaluation of H 3 R Ligand-Induced [ 35 S]GTP␥S Binding upon Coexpression of 7TM-H 3 R and 6TM-rH 3 Isoforms
Creation of rH 3A R G␣ Fusion Proteins. 125 IPP for the wild-type rH 3A R of 8.2 Ϯ 0.1. In addition, the affinities of the wild-type rH 3A R and the rH 3A R-G␣ o1 C 351 I fusion protein for the H 3 R agonist immepip and the inverse H 3 R agonist thioperamide are similar (6.5 Ϯ 0.2 and 7.7 Ϯ 0.1 versus 6.9 Ϯ 0.1 and 7.9 Ϯ 0.1, respectively).
Subsequently, we compared the capability of the rH 3A R-G␣ o1 C 351 I fusion protein to mediate the inhibition of 10 mM forskolin-induced activation of cAMP response element-mediated gene transcription in COS-7 cells. We found the rH 3A R-G␣ o1 C 351 I fusion protein to potently inhibit the forskolin-induced response upon activation with H 3 R agonists. In concert with our findings on the wild-type rH 3A R, treatment of cells cotransfected with cDNAs encoding the rH 3A R- values of approximately 4, 30, and 76 nM, respectively (Fig.  6A) . These data indicate that the rH 3A R-G␣ o1 C 351 I fusion protein is fully functional and shows an rH 3A R pharmacology.
Coexpression of rH 3A R-G␣ o1 C 351 I Fusion Proteins and the rH 3D Isoform. Consistent with our findings on the coexpression of 7TM-rH 3A Rs with the 6TM-rH 3 isoforms (see Fig. 5 ), coexpression of the rH 3A R-G␣ o1 C 351 I fusion protein together with the rH 3D isoform, results in an rH 3D -isoform gene-dosage dependent reduction of rH 3A R-G␣ o1 C 351 I fusion protein-derived 125 IPP binding sites (Fig. 6B) , and the remaining 125 IPP binding sites exhibit an rH 3A R-G␣ o1 C 351 Ilike pharmacological profile (pK b for 125 IPP, 8.5 Ϯ 0.1; pK i values for immepip and thioperamide, 7.0 Ϯ 0.2 and 7.6 Ϯ 0.1, respectively). The maximal inhibition of rH 3A R-G␣ o1 C 351 I-derived 125 IPP binding sites, as evaluated by a transfection of cells with an rH 3A R-G␣ o1 /rH 3D isoform cDNA ratio of 1:10 is ϳ65% (Fig. 6B) .
We subsequently assessed the influence of coexpression of the rH 3D isoform on the [
35 S]GTP␥S binding induced by agonist-mediated activation of coexpressed rH 3A R-G␣ o1 C 351 I fusion proteins. The H 3 R agonist immepip (1 mM) resulted in a robust stimulation of [
35 S]GTP␥S binding in rH 3A R-G␣ o1 C 351 I expressing cells that was inhibited by coincubation with a 1 mM concentration of the inverse H 3 R agonist thioperamide (Fig. 6C) . Under the assay conditions used, we could not detect significant thioperamide-mediated inhibition of basal rH 3A R-G␣ o1 C 351 I mediated [ 35 S]GTP␥S binding, indicating that we could not detect constitutive rH 3A R-G␣ o1 C 351 I activity. The 1 mM immepip-induced [ 35 S]GTP␥S binding was inhibited by 70% by coexpression of the rH 3A R-G␣ o1 C 351 I fusion protein with the rH 3D isoform (Fig. 6C) . The 6TM-rH 3 isoforms themselves did not mediate changes in [ 35 S]GTP␥S binding upon incubation with H 3 R ligands (data not shown).
Can rH 3 Rs Form Homo-Oligomers? In view of the emerging concept of GPCR dimerization that is now well documented in literature (for review, see, for example, Pfleger and Eidne, 2005) , we speculated that the 6TM-rH 3 isoforms might interfere with the cell surface expression of 7TM-rH 3 receptors through dimerization.
We have described the generation of anti-rH 3C 268-277Cys antibodies (Shenton et al., 2005) , which, based on immunoblotting, selectively recognize both the rH 3A R and rH 3C R isoform, but not the rH 3B R isoform expressed in HEK 293 cells. Wild-type rH 3A R-expressing cells were collected and subjected to cross-linking with varying amounts of the cell permeable cross-linker bis(sulfosuccinimidyl)suberate (BS3) before resolving the samples using SDS-PAGE. Immunoblotting with anti-H 3C 268-277Cys antibody yielded three major protein species (M r 90,000, 135,000, and ϳ200,000, respectively), corresponding well to putative dimeric, trimeric and tetrameric rH 3A R oligomers, respectively (Fig. 7, lanes 1-3) . Performing similar experiments using native rat brain tissue, the major species observed is a coincident M r 90,000 species (Fig. 7, lane 4) . It is noteworthy that a recombinant putative monomeric M r 47,000 species was clearly observed, which was barely detectable in the native forebrain preparation. Higher cross-linker concentrations yielded Ͼ200,000 species for both recombinant and native H 3 R preparations (Shenton et al., 2005) .
We have successfully used the time-resolved FRET (tr-FRET) fluorescence (665-nm emission after excitation at 320 nm) for the detection of hH 1 R dimerization using epitopetagged hH 1 Rs and fluorescently labeled antibodies recognizing the N-terminally epitope-tagged receptors (Bakker et al., 2004a) . We have used this approach to confirm the formation of oligomerization of rH 3 Rs.
tr-FRET fluorescence results obtained with the different samples are shown in Fig. 7B . A clear specific tr-FRET signal is observed using live cells expressing the HA-rH 3A Rs. The data are presented as the tr-FRET that is observed using HA-rH 3A R-expressing cells that have been incubated with both anti-HA-Eu 3ϩ and anti-HA-allophycocyanin antibodies versus the tr-FRET that is observed using a mix of two populations of HA-rH 3A R-expressing cells that before mixing were independently incubated with either of the two antibodies. The increased tr-FRET signal can only be explained by the resonance energy transfer from anti-HA-Eu 3ϩ antibodies bound to HA-rH 3A Rs to anti-HA-allophycocyanin antibodies bound to HA-rH 3A Rs, indicative of the formation of rH 3A R multimers in living cells.
Modulation of rH 3AD and rH 3DEF Isoform-Specific mRNAs in Rat Brain after Delivery of a Systemic Convulsant. We have successfully used specific oligonucleotide probes to characterize the 7TM-rH 3 R mRNA expression in the rat brain (Drutel et al., 2001) . To evaluate the CNS expression of the 6TM-rH 3 isoforms, we have designed domain specific probes. We have used one probe specific for the C terminus present in the 6TM-rH 3 isoforms, and, for comparison, we have also performed studies using a oligonucleotide probe specific for the (full-length) third intracellular loop of the rH 3A R, which is also present in the rH 3D isoform Fig. 7 . Detection of oligomerization of heterologous and native rH 3A Rs. A, biochemical evidence for rH 3A R oligomers. Membranes derived from either cells heterologously expressing rH 3A Rs or from native rat forebrain membranes were analyzed by immunoblotting (lanes 1-3 and 4, respectively) as described under Materials and Methods. In addition, samples of membranes expressing rH 3A Rs were subjected to chemical cross-linking with either 0.12 mM or 0.25 mM BS3 (lanes 2 and 3, respectively) before immunoblotting. Lanes 1 to 3 were subsequently probed with rabbit anti-H 3C 268 -277Cys antibody (0.2 g/ml), and lane 4 was probed with rabbit anti-H 3 349 -358 antibody (1.5 g/ml). The immunoblot is representative of at least three separate experiments. The molecular mass standards are displayed on the left and are indicated in kilodaltons. B, detection of dimeric rH 3A Rs by tr-FRET. Upon measuring fluorescence emission at 665 nm, after excitation at 337 nm, tr-FRET signals are seen using live cells expressing HA-rH 3A Rs, because of the resonance energy transfer of specific HA-rH 3A Rs bound to anti-HA-Eu 3ϩ antibody to the specific HA-rH 3A Rs bound to anti-HA-allophycocyanin antibody. tr-FRET signals were seen only using membranes of HA-rH 3A R expressing cells that were coincubated with both the anti-HA-Eu 3ϩ (Eu 3ϩ ) antibody and the anti-HA-allophycocyanin (XL665) antibody (Eu 3ϩ ϩ XL665). Mixing of two populations of cells expressing HA-rH 3A Rs independently incubated with either anti-HA-Eu 3ϩ or anti-HA-allophycocyanin antibodies resulted in a reduced tr-FRET signal. Data are plotted as the tr-FRET that is observed using HA-rH 3A R expressing cells that have been incubated with both anti-HA-Eu 3ϩ and anti-HA-allophycocyanin antibodies versus the tr-FRET that is observed using a mix of two populations of HA-rH 3A R expressing cells that before mixing were independently incubated with either of the two antibodies.
(but not any of the other rH 3 isoforms identified to date; Fig. 8A ).
Significant increases in mRNA expression levels of H 3 R isoforms with full-length third intracellular loop (detected using probe H 3AD ) were observed in layers II-VIb of cortex (48 h after injection), caudate putamen (48 h after injection), piriform cortex (48 h after injection), and CA1 region of the hippocampus (24 h after injection) (Fig. 8B) after PTZ. Figure  8C illustrates mRNA expression levels and differences for H 3A and H 3D isoforms in representative sections from control and 48 h after injection animals.
In contrast, decreases in mRNA expression pattern of 6TM-rH 3 isoforms (detected using probe H 3DEF ) were observed in layers II-VIb of cortex (6 h after injection), piriform cortex (6, 24, and 48 after injection), CA1 region of the hippocampus (24 h after injection), and CA3 region of the hippocampus (24 h after injection) (Fig. 8D) . Figure 8E shows mRNA expression patterns and differences for 6TM-rH 3 isoforms in representative sections from control animals and animals 24 h after injection.
Discussion
Our search for additional alternative splice variants of the rH 3 R resulted in the identification of three mRNAs coding for heretofore uncharacterized rH 3 isoforms. In contrast to the known functional H 3 Rs, sequence analysis of these newly identified isoforms reveals that an additional splicing event occurs within a region corresponding to TM6, resulting in isoforms with an alternative C-terminal domain and isoforms that are predicted to possess only 6 TMs. The mRNAs encoding these 6TM-rH 3 isoforms are expressed in the rat brain with a distribution pattern that is similar to the previously identified functional 7TM-rH 3 Rs (Drutel et al., 2001) . Although there may be differences in the rate of synthesis, the inherent stability, and the rate of degradation of the various H 3 isoforms, resulting in differences in their expression levels, extensive analysis of the 6TM-rH 3 isoforms through heterologous expression studies, however, failed to identify any ligand-binding and functional signaling events modulated by these 6TM-rH 3 isoforms. The 6TM-rH 3 isoforms seem to be localized intracellularly, and succeeding studies revealed the ability of the 6TM-rH 3 isoforms to interfere with the cell surface expression and subsequent signaling of the previously identified 7TM-rH 3 isoforms, thus acting as dominantnegative isoforms.
An increasing number of GPCRs have been shown to exist as oligomeric complexes (for review, see, for example, Pfleger and Eidne, 2005) , which are thought to be formed early molpharm.aspetjournals.org during biosynthesis (Terrillon et al., 2003) . In this study, we show also that the rH 3A R is present as dimers or higher order oligomeric complexes in both transfected cells and rat brain. The oligomerization of GPCRs during biosynthesis and maturation seems crucial for proper exportation of receptors to the plasma membrane (for review, see Bulenger et al., 2005) . The coexpression and formation of heterodimeric ␤ 2 -ARs (Hague et al., 2004a) aids, for instance, the cell surface trafficking of olfactory GPCRs that are otherwise retained and degraded in the ER (Lu et al., 2003 (Lu et al., , 2004 , as well as of the ␣ 1D -AR that normally is trafficked poorly to the cell surface (Uberti et al., 2005) . The coexpression of differentially spliced GPCR variants may also aid the cell-surface expression, as shown for instance by the coexpression of the ␣ 1D -AR with ␣ 1B -ARs (Hague et al., 2004b) . In contrast, certain alternatively spliced variants of, for instance, the ␣ 1A -AR (Cogé et al., 1999) , the calcitonin receptor (Seck et al., 2003) , and the dopamine D 3 receptor (Karpa et al., 2000) seem to dimerize with their cognate full-length receptors and impede their cell surface expression because of mislocalization to an intracellular compartment. The coexpression of the 6TM-rH 3 isoforms described herein not only reduced cell surface expression of the 7TM-rH 3 Rs but also consequently resulted in a reduced 7TM-rH 3 R-mediated signaling. Our data are therefore consistent with the reported findings on the coexpression of N-terminal truncated, dominant-negative mutants and wild-type V 2 receptors, which results in the formation of heterodimers and reduced agonist binding, signal transduction, and cell-surface trafficking of the full-length V 2 receptor (Zhu and Wess, 1998) . Similar to our findings on the 6TM-rH 3 isoforms, mutants of the ␣ 2 -AR (Zhou et al., 2006) , vasopressin V 2 (Zhu and Wess, 1998) , dopamine D 2 , chemokine receptor CCR5 (Benkirane et al., 1997; Blanpain et al., 2000; Chelli and Alizon, 2001 ), gonadotropinreleasing hormone receptor (Brothers et al., 2004) , and the platelet-activating factor (Le Gouill et al., 1999) receptors also impede the cell surface expression of their coexpressed wild-type counterparts, thus exhibiting trans-dominant-negative effects on wild-type receptor expression (Benkirane et al., 1997; Chelli and Alizon, 2001; Brothers et al., 2004) , most likely through dimerization. It seems most likely that the 6TM-rH 3 isoforms interfere with the functional expression of the 7TM-rH 3 Rs through heterodimerization. Although direct heterodimerization of the 6TM-rH 3 isoforms with the 7TM-rH 3 Rs remains to be established, we have shown the rH 3A R to be constitutively expressed as a dimeric receptor in the brain as well as upon heterologous expression.
GPCRs have been found to interact with accessory proteins, which can be critical for their biogenesis (for review, see Metherell et al., 2005) . A conserved F(X) 6 LL motif, which is suggested to be important for the proper GPCR folding and subsequent export from the ER (Duvernay et al., 2004) , is also present in the C-terminal domain of the 7TM-rH 3 Rs but is lacking in the 6TM-rH 3 isoforms. Mutations in regions overlapping the F(X) 6 LL motif in the dopamine D 1 receptor resulted in ER retention of the mutant receptor and loss of cell surface expression, and subsequent studies revealed that this region is important for a interactions with a specific ER-membrane-associated protein that regulates transport of GPCRs . It is noteworthy that, instead of the F(X) 6 LL motif, the 6TM-rH 3 isoforms possess an RXR ER retention signal. Taken together, these data suggest that the 6TM-rH 3 isoforms lack protein-protein interactions with specific accessory proteins in the ER that are required for cell-surface expression. Although the localization of the 6TM-rH 3 isoforms within the ER seems likely, this needs to be verified by future experiments. Nonetheless, the findings on GPR30 as an intracellular GPCR (Revankar et al., 2005) points out that the 6TM-rH 3 isoforms may well have yet undiscovered intracellular functions in addition to their capability to retain the 7TM-rH 3 Rs intracellularly.
On the one hand, the 6TM-rH 3 splice variants may act as "antichaperones" inhibiting specific chaperones' activities or preventing their access to the 7TM-rH 3 Rs. On the other hand, the association of the 6TM-rH 3 isoforms with the 7TM-rH 3 R isoforms in the ER may actively unfold or result in the misfolding of the protein complex. Because we find that the rH 3D isoform does not interfere with the cell surface expression of unrelated GPCRs, it seems unlikely the 6TM-rH 3 isoforms act through blocking either the ER or Golgi, or to promote ER-associated protein degradation. The precise mechanism underlying the action of the newly identified isoforms, however, remains unknown. Our data suggest that the regulation of the alternative rH 3 R mRNA splicing is a new and effective means for the regulation of H 3 R signaling. Functional (including constitutive) H 3 R activity may be regulated through the regulation of the splicing events underlying the occurrence of the various H 3 R isoforms. It is noteworthy that several cell signaling pathways, including the MAPK pathway, regulate mRNA splicing (reviewed in Shin and Manley, 2004) . It is intriguing that the H 3 R activates the MAPK pathway (Drutel et al., 2001; Giovannini et al., 2003) , arguing for the possibility of activation of splicing factors and hence, an autoregulation of the H 3 R activity.
Our studies also show that the expression pattern of the 7TM-rH 3 Rs and the 6TM-rH 3 isoforms overlaps substantially in rat brain. Moreover, PTZ-induced seizures result in suppression of 6TM-rH 3 (probe H 3DEF ) isoform mRNAs in particular brain regions, whereas mRNA levels of the isoforms with the full third intracellular loop (probe H 3AD ) are increased. A characteristic transient and short-living increase in the mRNA for the full-length third intracellular loop (probe H 3AD ), hippocampal CA 3c area, followed by piriform cortex, amygdala, and hippocampal CA 1 area is observed after systemic injection of kainic acid, a model of temporal lobe epilepsy (Lintunen et al., 2005) , indicating a spatiotemporal correlation to progressing neuronal damage in this model of temporal epilepsy. Previous studies on PTZ have indicated damaged neurons in the rostral limbic cortex (both the orbital, agranular insular, and prelimbic), the lateral hypothalamus (in the vicinity of the rostral medial forebrain bundle), the bed nucleus of the stria terminalis, the claustrum, the hippocampal formation (CA3 and entorhinal cortex), and lateral thalamic nuclei 50 min after injection (Ben-Ari et al., 1981) . The increases in H 3 R mRNA with full third intracellular loop as observed in this study after PTZ were observed significantly later than the reported damage begins (Ben-Ari et al., 1981) , in agreement with the concept that the mechanisms of neuronal damage after kainic acid and PTZ are different. Although the piriform cortex has not been reported to suffer significant damage after PTZ (BenAri et al., 1981) , it seems not to be only a primary sensory area but because of its neuronal organization and associative fiber system may also be involved in the pathological mechanisms leading to seizures (Löscher and Ebert, 1996) . Of the areas studied here, the piriform cortex showed a sustained decline in 6TM-rH 3 mRNA expression. We observed a significant transient increase in H 3 R radioligand binding in piriform cortex at 6 h after PTZ concomitantly with the decline of H 3DEF isoform mRNAs (data not shown). However, a similar strong correlation was not found in all areas where smaller changes were seen, suggesting that other factors in addition to mRNA ratios may affect receptor binding. The high susceptibility for induction of seizures by chemical or electrical stimulation and various studies addressing its role in seizure generation suggest that the piriform cortex can also function as an amplifier region to increase and propagate seizure activity induced in other limbic regions (Löscher and Ebert, 1996) . Increased H 3 R activity (e.g., expression and translation) in this region could result in decreased glutamate release (Brown and Haas, 1999; Molina-Hernandez et al., 2001) , because glutamatergic neurons exist in the piriform cortex (Riba-Bosch and Perez-Clausell, 2004) , for control of overall neuronal activity in the region.
The abundance of mRNA coding for the 6TM-rH 3 isoforms suggest that its production may have important biological implications. For example, in addition to its ability to interfere with cell surface expression of functional rH 3 Rs, which may arise from modification of the stability of the mRNA encoding functional 7TM-rH 3 Rs, the 6TM-rH 3 isoform mRNAs might encode proteins with yet unidentified functions. Further analysis of the alternatively spliced products of the H 3 R gene is required to elucidate their biological significance.
In conclusion, we have identified three additional splice variants of the rH 3 R. The mRNAs of these isoforms are abundantly expressed in the brain and the expression pattern largely overlaps with that of the known rH 3A-C R isoforms. Analysis of the sequence of these rH 3D , rH 3E , and rH 3F isoforms reveals these isoforms to consist of 6TM domains. The 6TM-rH 3 isoforms are retained intracellularly upon heterologous expression, and in subsequent pharmacological analysis studies we could detect no ligand binding or functional activity for these 6TM-rH 3 isoforms. The 6TM-rH 3 isoforms, however, selectively impede cell surface expression of the functional 7TM-rH 3 Rs. Moreover, the mRNA levels of the rH 3 isoforms in rat brain are modulated by treatment with the convulsant PTZ. Although the functional significance and possible roles of these 6TM-rH 3 isoforms in (patho)physiology remain to be established, these findings provide novel insight in the regulation of the histaminergic system in the brain.
